Showing results (111-120 of 254) with videos related to

Sort By:
Pageof 26
Clinical Lymphoma, Myeloma & Leukemia|November 12, 2013
Low uptake of upfront autologous transplantation for myeloma in a jurisdiction with universal health care coverage: a population-based patterns of care study in AustraliaNicole Wong Doo, Michael Coory, Victoria White, et al.
Leukemia & Lymphoma|October 14, 2010
Fludarabine based combinations are highly effective as first-line or salvage treatment in patients with Waldenström macroglobulinemiaStefan Peinert, Constantine S Tam, H Miles Prince, et al.
Hematological Oncology|December 7, 2011
Emergence of central nervous system myeloma in the era of novel agentsShane A Gangatharan, Dennis A Carney, H Miles Prince, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapyH Miles Prince, Geoff Regester, Priscilla Gates, et al.
Cancer|July 19, 2006
The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disordersMark N Polizzotto, Constantine S Tam, Alvin Milner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2018
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)Andrew Wirth, H Miles Prince, Daniel Roos, et al.
Cancers|November 14, 2019
Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis FungoidesBelinda A Campbell, Gail Ryan, Christopher McCormack, et al.
Annals of Hematology|April 11, 2008
Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patientsSaar Gill, Steven W Lane, Julie Crawford, et al.
The Lancet. Haematology|April 1, 2016
Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the ALLG MM6 multicentre, open-label, randomised phase 3 studyAnna Kalff, Nola Kennedy, Angela Smiley, et al.
Leukemia & Lymphoma|October 27, 2006
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancySteven W Lane, Julie Crawford, Melita Kenealy, et al.
Pageof 26